IN VIVO EFFECTS OF IL 2--ROLE OF TNF AND TNF R FAMILIES
IL 2 的体内作用——TNF 和 TNF R 家族的作用
基本信息
- 批准号:2646453
- 负责人:
- 金额:$ 21.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-04-01 至 2000-03-31
- 项目状态:已结题
- 来源:
- 关键词:CD40 molecule cytokine cytokine receptors epidermal growth factor flow cytometry human tissue immunopharmacology interleukin 2 laboratory mouse leukocyte adhesion molecules neoplasm /cancer immunotherapy neoplasm /cancer remission /regression receptor expression surface antigens tissue /cell culture transforming growth factors tumor necrosis factor alpha vascular endothelium permeability western blottings
项目摘要
With the exception of TNF and LT (both of which are secreted),
members of the TNF family are membrane-associated T cell activation
antigens, several of which are induced by IL-2. Receptors of these
proteins (e.g. fas, CD40, the LT-beta receptor) are members of the
TNF receptor family known primarily for their roles in B cell help
(CD40), the induction of apoptosis (fas), or lymph node development
(the LT-beta-R). Fas, CD40, and theLT-beta receptor have recently
been demonstrated on the endothelium, where their functions are
largely unknown. However, like the p55 TNF receptor, CD40
engagement has been shown to elicit adhesion molecule expression in
these cells, thus raising the possibility that these TNF receptor family
members may transmit signals upon contact with activated lymphocytes
that are qualitatively similar to those induced by TNF itself. In
addition to fas and the p55 TNF receptor, both CD40 and the LT-beta
receptor were recently shown to transmit apoptotic signals in certain
tumor cell lines, suggesting that they may play a role in tumor cell
cytolysis mediated by IL-2-primed lymphocytes. The studies we have
proposed in this application will assess the ability of IL-2 to induce the
expression of membrane-associated TNF family members in various
lymphoid populations in vitro and in vivo. The factors regulating the
expression of their respective receptors (e.g. fas, CD40, the LT-beta
receptor) on cultured endothelial cells and on skin and tumor-associated
endothelium will also be determined. Several studies with tumor-
bearing mice are proposed to assess the role played by the fas-L,
CD40-L and 'membrane LT' present on IL-2-activated lymphocytes in
IL-2-induced tumor regression and endothelial injury. Ultimately,
these studies will address the feasibility of using fas-IgG, CD40-IgG,
LT-beta receptor-IgG fusion proteins to attenuate the microvascular
pathology resulting from the administration of IL-2.
除肿瘤坏死因子和凝血酶原激活剂(均为分泌型)外,
肿瘤坏死因子家族的成员是膜相关T细胞活化
抗原,其中一些是由IL-2诱导的。它们的受体
蛋白质(如Fas、CD40、LT-β受体)是
肿瘤坏死因子受体家族主要因其在B细胞帮助中的作用而闻名
(CD40)、诱导细胞凋亡(Fas)或淋巴结发育
(LT-β-R)。Fas、CD40和LT-β受体最近
已经在内皮细胞上展示过,在那里它们的功能是
很大程度上是未知的。然而,与p55肿瘤坏死因子受体一样,CD40
参与已被证明能诱导黏附分子在脑内的表达
这些细胞,从而增加了这些肿瘤坏死因子受体家族
成员可以在与激活的淋巴细胞接触时传递信号
在性质上与肿瘤坏死因子本身所诱导的相似。在……里面
除了Fas和p55肿瘤坏死因子受体,CD40和LT-β也是如此
最近发现,受体在某些情况下传递凋亡信号。
肿瘤细胞系,提示它们可能在肿瘤细胞中发挥作用
IL-2激活的淋巴细胞介导的细胞杀伤作用。我们已有的研究
在本申请中提出的将评估IL-2诱导
膜相关肿瘤坏死因子家族成员在不同组织中的表达
体外和体内的淋巴种群。规范这一现象的因素
它们各自的受体(如Fas、CD40、LT-β)的表达
受体)在培养的血管内皮细胞、皮肤和肿瘤相关细胞上的表达
血管内皮细胞也将被测定。几项关于肿瘤的研究-
建议用带胎小鼠来评估FAS-L的作用,
CD_(40)-L和‘膜LT’在IL-2激活的淋巴细胞上的表达
IL-2诱导的肿瘤消退和内皮损伤。最终,
这些研究将探讨使用Fas-Ig G、CD40-Ig G、
LT-β受体-免疫球蛋白融合蛋白抑制微血管的研究
因使用IL-2而导致的病理改变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES W MIER其他文献
JAMES W MIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES W MIER', 18)}}的其他基金
Targeting Raf in Melanoma: Mechanisms for Effect & Resistance & Opportunities for
靶向 Raf 治疗黑色素瘤:作用机制
- 批准号:
7464270 - 财政年份:2008
- 资助金额:
$ 21.96万 - 项目类别:
PHASE I CLINICAL TRIAL OF DECITABINE PRIOR TO DACARBAZINE IN ADVANCED MELANOMA
达卡巴嗪治疗晚期黑色素瘤中地西他滨的 I 期临床试验
- 批准号:
7205190 - 财政年份:2005
- 资助金额:
$ 21.96万 - 项目类别:
IN VIVO EFFECTS OF IL 2--ROLE OF TNF AND TNF R FAMILIES
IL 2 的体内作用——TNF 和 TNF R 家族的作用
- 批准号:
2683717 - 财政年份:1997
- 资助金额:
$ 21.96万 - 项目类别:
IN VIVO EFFECTS OF IL 2--ROLE OF TNF AND TNF R FAMILIES
IL 2 的体内作用——TNF 和 TNF R 家族的作用
- 批准号:
2895972 - 财政年份:1997
- 资助金额:
$ 21.96万 - 项目类别:
相似海外基金
How do cytokine receptors transmit signals?
细胞因子受体如何传递信号?
- 批准号:
DP230102422 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Projects
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2022
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Grants Program - Individual
Deciphering novel cross-talk between innate cytokine receptors
破译先天细胞因子受体之间的新型串扰
- 批准号:
DP210103122 - 财政年份:2021
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Projects
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2021
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Grants Program - Individual
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2020
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Grants Program - Individual
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2019
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Grants Program - Individual
A dissection of transmembrane signal transduction and downstream signaling response in cytokine receptors
细胞因子受体跨膜信号转导和下游信号反应的剖析
- 批准号:
412345 - 财政年份:2019
- 资助金额:
$ 21.96万 - 项目类别:
Fellowship Programs
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2018
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Grants Program - Individual
Development of analysis method of inflammation-related proteins in serum using inflammatory cytokine receptors
开发利用炎症细胞因子受体分析血清中炎症相关蛋白的方法
- 批准号:
17K18360 - 财政年份:2017
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Mutations and single nucleotide polymorphisms of cytokine receptors in Kawasaki disease
川崎病细胞因子受体突变及单核苷酸多态性
- 批准号:
16K10020 - 财政年份:2016
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)